Protein kinase C (PKC)-δ/-ε mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin

Journal of Endocrinology

Volumn 188, Issue 1, 2006, Pages 79-89

  Greco, S ^a   Storelli, C ^a   Marsigliante, Santo ^a  

^a Ecotekne ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

12 (2 CYANOETHYL) 6,7,12,13 TETRAHYDRO 13 METHYL 5 OXOINDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 [1 (3 DIMETHYLAMINOPROPYL) 3 INDOLYL] 3 (3 INDOLYL)MALEIMIDE; 2 MORPHOLINO 8 PHENYLCHROMONE; BRADYKININ; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; PROTEIN KINASE C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C DELTA; PROTEIN KINASE C EPSILON; PROTEIN KINASE C INHIBITOR;

ARTICLE; BREAST CANCER; CANCER CELL; CELL MEMBRANE; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN MCF 7; CYTOSOL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANALYSIS OF VARIANCE; BIOLOGICAL TRANSPORT; BRADYKININ; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CELL PROLIFERATION; CHROMONES; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRENES; FEMALE; FLAVONOIDS; HUMANS; IMMUNOBLOTTING; INDOLES; KALLIDIN; MALEIMIDES; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MORPHOLINES; PHOSPHORYLATION; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; PROTEIN KINASE C-EPSILON; PYRROLIDINONES; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; STIMULATION, CHEMICAL; TETRAHYDROISOQUINOLINES;

EID: 31544460112     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06433     Document Type: Article

References (48)

1. 2 receptor-mediated mitogen-activated protein kinase activation in COS-7 cells requires dual signalling via both protein kinase C pathway and epidermal growth factor receptor transactivation. Molecular Cell Biology 19 5289-5297.
2. Akimoto K, Takahashi R, Moriya S, Nishioka N, Takayanagi J, Kimura K, Fukui Y, Osada S, Mizuno K, Hirai S, Kazlauskas A & Ohno S 1996 EGF or PDGF receptors activate atypical PKClambda through phosphatidylinositol 3-kinase. EMBO Journal 15 788-798.
3. Alessi DR, Cuenda A, Cohen P, Dudley DT & Saltiel AR 1995 PD098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. Journal of Biological Chemistry 270 27489-27494.
4. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P & Hemmings BA 1996 Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO Journal 13 6541-6551.
5. Ankorina-Stark I, Haxelmans S & Schlatter E 1997 Receptors for bradykinin and prostaglandin E2 coupled to Ca2+ signalling in rat cortical collecting duct. Cellular Calcium 22 269-275.
6. Barki-Harrington L & Daaka Y 2001 Bradykinin induced mitogenesis of androgen independent prostate cancer cells. Journal of Urology 165 2121-2125.
7. Clark KJ & Murray AW 1995 Evidence that the bradykinin-induced activation of phospholipase D and of the mitogen-activated protein kinase cascade involve different protein kinase C isoforms. Journal of Biological Chemistry 270 7097-7103.
8. Clements J & Mukhtar A 1977 Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers. Immunopharmacology 36 217-220.
9. Clerk A, Gillespie-Brown J, Fuller SJ & Sudgen PH 1996 Stimulation of phosphatidylinositol hydrolysis, protein kinase C translocation, and mitogen-activated protein kinase activity by bradykinin in rat ventricular myocytes: dissociation from the hypertrophic response. Biochemical Journal 317 109-118.
10. Crowder RJ & Freeman RS 1998 Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons. Journal of Neuroscience 18 2933-2943.
11. Dikic I, Tokiwa G, Lev S, Courtneidge SA & Schlessinger J 1996 A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383 547-549.
12. Dlamini Z, Raidoo D & Bhoola K 1999 Visualisation of tissue kallikrein and kinin receptors in oesophageal carcinoma. Immunopharmacology 43 303-310.
13. 2 receptor antagonist, Hoe 140 (Icatibant), may act as mitogenic agonist. British Journal of Pharmacology 131 1553-1560.
14. 2 receptors in the rat kidney: implications for segmental nephron maturation. Kidney International 51 739-749.
15. 2+ increase stimulated by pyrophosphonucelotides and bradykinin in mammary tumour cells. Cell Biochemistry and Function 13 279-286.
16. Flemming I, Fisslthaler B & Busse R 1995 Calcium signalling in endothelial cells involves activation of tyrosine kinases and leads to activation of mitogen-activated protein kinases. Circulation Research 76 522-529.
17. Frey BM, Reber BF, Vishwanath BS, Escher GV & Frey FJ 1999 Annexin I modulates cell functions by controlling intracellular calcium release. FASEB Journal 13 2235-2245.
18. q/11 protein, phosphatidylinositol 3-kinase β, and protein kinase C ε. Journal of Biological Chemistry 273 32016-32022.
19. Graness A, Hanke S, Boehmer FD, Presek P & Liebmann C 2000 Protein-tyrosine-phosphatase-mediated epidermal growth factor (EGF) receptor transinactivation and EGF receptor-independent stimulation of mitogen-activated protein kinase by bradykinin in A431 cells. Biochemical Journal 347 441-447.
20. Greco S, Muscella A, Elia MG, Salvatore P, Storelli C, Mazzotta A, Manca C & Marsigliante S 2003 Angiotensin II activates extracellular signal regulated kinases via protein kinase C and epidermal growth factor receptor in breast cancer cells. Journal of Cellular Physiology 196 370-377.
21. Greco S, Muscella A, Elia MG, Romano S, Storelli C & Marsigliante S 2004 Mitogenic signalling by B2 bradykinin receptor in epithelial breast cells. Journal of Cell Physiology 201 84-96.
22. Greco S, Elia MG, Muscella A, Romano S, Storelli C & Marsigliante S 2005 Bradykinin stimulates cell proliferation through an ERK1/2-dependent mechanism in breast cancer cells in primary culture. Journal of Endocrinology 186 291-301.
23. Hall JM 1992 Bradykinin receptors: pharmacological properties and biological roles. Pharmacological Therapy 56 131-190.
24. Hawes BE, Luttrell LM, van Biesen T & Lefkowitz RJ 1996 Phosphatidylinositol 3-kinase is an early intermediate in the Gβγ-mediated mitogen-activated protein kinase signalling pathway. Journal of Biological Chemistry 271 12133-12136.
25. Hermann A, Buchinger P & Rehbock J 1995 Visualization of tissue kallikrein in human breast carcinoma by two-dimensional Western blotting and immunohistochemistry. Biological Chemistry Hoppe-Seyler 376 365-370.
26. Jaffa AA, Miller BS, Rosenzweig SA, Naidu PS, Velarde V & Mayfield RK 1997 Bradykinin induces tubulin phosphorylation and nuclear translocation of MAP kinase in mesangial cells. American Journal of Physiology 273 F916-F924.
27. Konishi H, Matsuzaki H, Tanaka M, Ono Y, Tokunaga C, Kuroda S & Kikkawa U 1996 Activation of RAC-protein kinase by heat shock and hyperosmolarity stress through a pathway independent of phosphatidylinositol 3-kinase. PNAS 93 7639-7643.
28. Kranenburg O, Verlaan I, Hordijk PL & Moolenaar WH 1997 Gi-mediated activation of the Ras/MAP kinase pathway involves a 100 kDa tyrosine-phosphorylated Grb2 SH3 binding protein, but not Src nor Shc. EMBO Journal 16 3097-3105.
29. Lafon C, Mazars P, Guerrin M, Barboule N, Charcosset JY & Valette A 1995 Early gene responses associated with transforming growth factor-beta 1 growth inhibition and autoinduction in MCF-7 breast adenocarcinoma cells. Biochimical et Biophysica Acta 1266 288-295.
30. Ma JX, Wang DZ, Ward DC, Chen L, Dessai T, Chao J & Chao L 1994 Structure and chromosomal localisation of gene (BDKRB2) encoding the bradykinin B2 receptor. Genomics 23 362-369.
31. Marceau F 1995 Kinin B1 receptors: a review. Immunopharmacology 30 1-26.
32. Moriya S, Kazlauskas A, Akimoto K, Hirai S, Mizuno K, Takenawa T, Fukui Y, Watanabe Y, Ozaki S & Ohno S 1996 Platelet-derived growth factor activates protein kinase C epsilon through redundant and independent signaling pathways involving phospholipase C gamma or phosphatidylinositol 3-kinase. PNAS 93 151-155.
33. Muscella A, Greco S, Elia MG, Storelli C & Marsigliante S 2003 PKC-ζ is required for angiotensin II-induced activation of ERK and synthesis of c-fos in MCF-7 cells. Journal of Cellular Physiology 197 61-68.
34. 2 kinin receptors causes activation of the MAP kinase signalling pathway, resulting in the translocation of AP-1 in HEK 293 cells. FEBS Letters 435 96-100.
35. +-ATPase activity. Methods in Enzymology 156 116-123.
36. Pesquero JB & Bader M 1998 Molecular biology of the kallikrein-kinin system: from structure to function. Brazilian Journal of Medical and Biological Research 31 1197-1203.
37. Plendl J, Snyman C, Naidoo S, Sawant S, Mahabeer R & Bhoola KD 2000 Expression of tissue kallikrein and kinin receptors in angiogenic microvascular endothelial cells. Biological Chemistry 38 1103-1115.
38. Regoli D & Barabè J 1980 Pharmacology of bradykinin and related peptides. Pharmacological Review 32 1-46.
39. Riera MF, Meroni SB, Pellizzari EH & Cigorraga SB 2003 Assessment of the roles of mitogen-activated protein kinase and phosphatidyl inositol 3-kinase/protein kinase B pathways in the basic fibroblast growth factor regulation of Sertoli cell function. Journal of Molecular Endocrinology 31 279-289.
40. Robert RM & Gulick WJ 1989 Bradykinin receptor number and sensitivity to ligand stimulation of mitogenesis by expression of mutant ras oncogene. Journal of Cellular Science 94 527-535.
41. Roymans D & Slegers H 2001 Phosphatidylinositol 3-kinases in tumor progression. European Journal of Biochemistry 268 487-498.
42. Traub O, Monia BP, Dean NM & Berk BC 1997 PKC-epsilon is required for mechano-sensitive activation of ERK1/2 in endothelial cells. Journal of Biological Chemistry 272 31251-31257.
43. Vavrek R & Stewart JM 1985 Competitive antagonists of bradykinin. Peptides 6 161-164.
44. Vlahos CJ, Matter WF, Hui KY & Brown RF 1994 A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Journal of Biological Chemistry 269 5241-5248.
45. Wennstrom S & Downward J 1999 Role of phosphoinositide 3-kinase in activation of Ras and mitogen-activated protein kinase by epidermal growth factor. Molecular Cell Biology 19 4279-4288.
46. Wiernas TK, Davis TL, Griffin BW & Sharif NA 1998 Effects of bradykinin on signal transduction, cell proliferation, and cytokine, prostaglandin E2 and collagenase-1 release from human corneal epithelial cells. British Journal of Pharmacology 123 1127-1137.
47. Zhang J, Falck JR, Reddy KK, Abrams CS, Zhao W & Rittenhouse SE 1995 Phosphatidylinositol (3,4,5)-trisphosphate stimulates phosphorylation of pleckstrin in human platelets. Journal of Biological Chemistry 270 22807-22810.
48. Zwick E, Daub H, Aoki N, Yamaguchi-Aoki Y, Tinhofer I, Maly K & Ullrich A 1997 Critical role of calcium-dependent epidermal growth factor receptor transactivation in PC12 cell membrane depolarization and bradykinin signalling. Journal of Biological Chemistry 272 24767-24770.